News & Events :: Veru Inc. (VERU)

Recent NewsView All News

Jun 11, 2025 8:30am EDT

Veru to Participate in the Virtual BTIG Obesity Health Forum

May 28, 2025 6:30am EDT

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

Upcoming Events View All Events

June 18, 2025

BTIG Obesity Health Forum

July 25, 2025 9:00 am EDT

Special Meeting of Shareholders

View All Events

Latest Presentation View All Presentations

Jones Healthcare and Technology Innovation Conference, April 2025

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings